ACER THERAPEUTICS
Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare, and life-threatening diseases with critical unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errors of metabolism, including urea cycle disorde... rs (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO™ (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.
ACER THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.acertx.com
Total Employee:
11+
Status:
Active
Total Funding:
74.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Athenex
Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-19 | Opexa Therapeutics | Opexa Therapeutics acquired by Acer Therapeutics | N/A |
Investors List
SWK Holdings
SWK Holdings investment in Post-IPO Debt - Acer Therapeutics
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
Key Employee Changes
Official Site Inspections
http://www.acertx.com Semrush global rank: 8.8 M Semrush visits lastest month: 254
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acer Therapeutics"
Corporate Presentation - Acer Therapeutics
4 acer acer management team chris schelling chief executive officer & founder. adrian quartel, md. chief medical officer. harry palmin. chief financial officerSee details»
Vice President of Quality - acertx.com
Oct 10, 2020 www.acertx.com. 2 . Company Overview . Acer Therapeutics is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for …See details»
Corporate Presentation - Acer Therapeutics
Jun 26, 2023 Symptoms of Hyperammonemia General – Growth retardation – Hypothermia Central – Combativeness – Lethargy – Coma Eyes – Papilledema Pulmonary Shortness of …See details»
Acer Therapeutics Inc. | LinkedIn
Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases …See details»
Acer Therapeutics Company Profile | Management and Employees …
Www.acertx.com Acer Therapeutics Profile and History Founded in 2013, Acer Therapeutics Inc. develops re-purposed and reformulated medicines to treat ultra-orphan diseases.See details»
Acer Therapeutics Inc (ACER) Profile - The Globe and Mail
See the company profile for Acer Therapeutics Inc (ACER) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Acer Therapeutics - Crunchbase Company Profile & Funding
The acquisition by a larger entity often comes with an influx of resources, expertise, and market access that can facilitate expansion and development of new therapies. Furthermore, being …See details»
Acer Therapeutics, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
Www.acertx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the Pipeline …See details»
Acer Therapeutics Inc. Information - RocketReach
Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases …See details»
Position Profile - Acer Therapeutics
Www.acertx.com. March 2021 . 2 . Company Overview . We are a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare …See details»
Acer Therapeutics: Employee Directory | ZoomInfo.com
Acer Therapeutics Employee Directory . Acer Therapeutics corporate office is located in 1 Gateway Ctr Ste 351, Newton, Massachusetts, 02458, United States and has 75 employees.See details»
Acer Therapeutics - Overview, News & Similar companies
Aug 31, 2023 Acer Therapeutics contact info: Phone number: (844) 902-6100 Website: www.acertx.com What does Acer Therapeutics do? Founded in 2013, Acer Therapeutics Inc. …See details»
Organization: Acer Therapeutics - Cbonds.com
Acer Therapeutics. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Acer Therapeutics Reacquires Worldwide Development,
Aug 30, 2023 [email protected] +1-844-902-6100. Nick Colangelo Gilmartin Group [email protected] +1-332-895-3226 ...See details»
November 2020 Nasdaq: ACER - Acer Therapeutics
Nov 10, 2020 Corporate Overview. Acer Therapeutics is a pharmaceutical company that acquires, develops and seeks to commercialize therapies for serious rare and life-threatening …See details»
Acer Therapeutics Inc. - Cruelty Free Investing
Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the …See details»
Acer Therapeutics to Participate in March Virtual Investor …
Mar 1, 2021 For more information, visit www.acertx.com. Investor Contact:Hans VitzthumLifeSci AdvisorsPh: [email protected] Jim DeNikeAcer Therapeutics Inc.Ph: …See details»
Vice President, Market Access & Reimbursement - Acer Therapeutics
Www.acertx.com September 2021 . 2 Company Overview We are a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare …See details»
Nancy Duarte-Lonnroth - Vice President, Quality at Acer
Dec 5, 2023 Nancy Duarte-Lonnroth contact details: Email address: n***@acertx.com Phone number: (***) ***-**** Who is Nancy Duarte-Lonnroth? Nancy Duarte-Lonnroth is a Vice …See details»
Senior/Executive Director, Clinical Operations - acertx.com
• Ability to interact with investigators, vendors, and individuals at all levels of the organization. Success Factors • Strong personal leadership skills to drive performance and support …See details»